BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31754211)

  • 1. LINC01149 variant modulates MICA expression that facilitates hepatitis B virus spontaneous recovery but increases hepatocellular carcinoma risk.
    Zhong R; Tian J; Fu M; Ma S; Liu L; Li J; Shen N; Ke J; Yang Y; Gong Y; Zhu Y; Wang Y; Gong J; Chang J; Lei P; Cheng X; Huang K; Shen G; Miao X
    Oncogene; 2020 Feb; 39(9):1944-1956. PubMed ID: 31754211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonreceptor protein tyrosine phosphatases (NRPTPs) gene family associates with the risk of hepatocellular carcinoma in a Chinese hepatitis B virus-related subjects.
    Shen N; Wang P; Li Y; Zhu Y; Gong Y; Zhong R; Lu Y; Cheng L
    Mol Carcinog; 2020 Aug; 59(8):980-988. PubMed ID: 32484301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of long non coding RNA genes is associated with expression with polymorphisms of HULC rs7763881 and MALAT1 rs619586 in hepatocellular carcinoma and HBV Egyptian patients.
    Motawi TMK; El-Maraghy SA; Sabry D; Mehana NA
    J Cell Biochem; 2019 Sep; 120(9):14645-14656. PubMed ID: 31009106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between the rs2596542 polymorphism in the MICA gene promoter and HBV/HCV infection-induced hepatocellular carcinoma: a meta-analysis.
    Luo X; Wang Y; Shen A; Deng H; Ye M
    BMC Med Genet; 2019 Aug; 20(1):142. PubMed ID: 31419949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge-based analyses reveal new candidate genes associated with risk of hepatitis B virus related hepatocellular carcinoma.
    Jiang D; Deng J; Dong C; Ma X; Xiao Q; Zhou B; Yang C; Wei L; Conran C; Zheng SL; Ng IO; Yu L; Xu J; Sham PC; Qi X; Hou J; Ji Y; Cao G; Li M
    BMC Cancer; 2020 May; 20(1):403. PubMed ID: 32393195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative analysis identifies genetic variant modulating MICA expression and altering susceptibility to persistent HBV infection.
    Gong Y; Cheng X; Tian J; Li J; Zhu Y; Yang Y; Zou D; Peng X; Luo J; Zhao L; Mei S; Wang X; Yang N; Ke J; Gong J; Chang J; Wang Y; Zhong R
    Liver Int; 2019 Oct; 39(10):1927-1936. PubMed ID: 31033131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
    Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus-induced hepatocellular carcinoma: functional roles of MICA variants.
    Tong HV; Toan NL; Song LH; Bock CT; Kremsner PG; Velavan TP
    J Viral Hepat; 2013 Oct; 20(10):687-98. PubMed ID: 24010643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptome-wide association study for persistent hepatitis B virus infection and related hepatocellular carcinoma.
    Han J; Chen C; Wang C; Qin N; Huang M; Ma Z; Zhu M; Dai J; Jiang Y; Ma H; Jin G; Shen H; Hu Z
    Liver Int; 2020 Sep; 40(9):2117-2127. PubMed ID: 32574393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble MICA and a MICA variation as possible prognostic biomarkers for HBV-induced hepatocellular carcinoma.
    Kumar V; Yi Lo PH; Sawai H; Kato N; Takahashi A; Deng Z; Urabe Y; Mbarek H; Tokunaga K; Tanaka Y; Sugiyama M; Mizokami M; Muroyama R; Tateishi R; Omata M; Koike K; Tanikawa C; Kamatani N; Kubo M; Nakamura Y; Matsuda K
    PLoS One; 2012; 7(9):e44743. PubMed ID: 23024757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of the mutations in basal core promoter of hepatitis B virus subgenotype C1 increase the risk of hepatocellular carcinoma in Southern China.
    Li W; Chen G; Yu X; Shi Y; Peng M; Wei J
    Int J Clin Exp Pathol; 2013; 6(6):1076-85. PubMed ID: 23696925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation at -1878 (rs2596542) in MICA gene region is associated with chronic hepatitis B virus infection in Saudi Arabian patients.
    Al-Qahtani AA; Al-Anazi M; Abdo AA; Sanai FM; Al-Hamoudi W; Alswat KA; Al-Ashgar HI; Khalaf N; Viswan N; Al-Ahdal MN
    Exp Mol Pathol; 2013 Dec; 95(3):255-8. PubMed ID: 23994040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N
    Rao X; Lai L; Li X; Wang L; Li A; Yang Q
    IUBMB Life; 2021 Feb; 73(2):408-417. PubMed ID: 33372396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus genotypes, expression quantitative trait loci for ZNRD1-AS1 and their interactions in hepatocellular carcinoma.
    Liu Z; Song C; Wen J; Xu L; Liu Y; Zhu J; Zhu L; Hu Z; Ma H; Liu L
    Oncotarget; 2016 Jul; 7(28):44076-44083. PubMed ID: 27286450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UBE2L3, a susceptibility gene that plays oncogenic role in hepatitis B-related hepatocellular carcinoma.
    Liu Y; Song C; Ni H; Jiao W; Gan W; Dong X; Liu J; Zhu L; Zhai X; Hu Z; Li J
    J Viral Hepat; 2018 Nov; 25(11):1363-1371. PubMed ID: 29969176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma.
    Sawai H; Nishida N; Khor SS; Honda M; Sugiyama M; Baba N; Yamada K; Sawada N; Tsugane S; Koike K; Kondo Y; Yatsuhashi H; Nagaoka S; Taketomi A; Fukai M; Kurosaki M; Izumi N; Kang JH; Murata K; Hino K; Nishina S; Matsumoto A; Tanaka E; Sakamoto N; Ogawa K; Yamamoto K; Tamori A; Yokosuka O; Kanda T; Sakaida I; Itoh Y; Eguchi Y; Oeda S; Mochida S; Yuen MF; Seto WK; Poovorawan Y; Posuwan N; Mizokami M; Tokunaga K
    Sci Rep; 2018 May; 8(1):7958. PubMed ID: 29784950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma.
    Yang HI; Yeh SH; Chen PJ; Iloeje UH; Jen CL; Su J; Wang LY; Lu SN; You SL; Chen DS; Liaw YF; Chen CJ;
    J Natl Cancer Inst; 2008 Aug; 100(16):1134-43. PubMed ID: 18695135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus X protein upregulates alpha-fetoprotein to promote hepatocellular carcinoma by targeting miR-1236 and miR-329.
    Zhang C; Liu P; Zhang C
    J Cell Biochem; 2020 Mar; 121(3):2489-2499. PubMed ID: 31680299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The miR-545/374a cluster encoded in the Ftx lncRNA is overexpressed in HBV-related hepatocellular carcinoma and promotes tumorigenesis and tumor progression.
    Zhao Q; Li T; Qi J; Liu J; Qin C
    PLoS One; 2014; 9(10):e109782. PubMed ID: 25299640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of a functional RAD52 genetic variant locating in a miRNA binding site with risk of HBV-related hepatocellular carcinoma.
    Li Z; Guo Y; Zhou L; Ge Y; Wei L; Li L; Zhou C; Wei J; Yuan Q; Li J; Yang M
    Mol Carcinog; 2015 Sep; 54(9):853-8. PubMed ID: 24729511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.